Evaluation of a bovine rotavirus VP6 vaccine efficacy in the calf model of infection and disease

Veterinary Immunology and Immunopathology

Volumn 137, Issue 1-2, 2010, Pages 155-160

  Gonzalez, Diego Daniel ^a   Mozgovoj, Marina Valeria ^a   Bellido, Demian ^a   Rodriguez, Daniela Vanesa ^a   Fernandez, Fernando María ^a   Wigdorovitz, Andrés ^a   Parreño, Viviana Gladys ^a   Dus Santos, María José ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Bovine rotavirus; Passive immunity; Recombinant VP6

Indexed keywords

BOVINE ROTAVIRUS VP6 VACCINE; IMMUNOGLOBULIN CLASS; PROTEIN VP6; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CALF (BOVINE); COLOSTRUM; CONTROLLED STUDY; COW; DIARRHEA; DRUG EFFICACY; FECES; FEMALE; INOCULATION; MALE; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PROTEIN EXPRESSION; ROTAVIRUS INFECTION; SERUM; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALIA; BOVINE ROTAVIRUS; BREDA VIRUS; HEXAPODA; MIRIDAE;

EID: 77955556507     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.04.015     Document Type: Article

References (25)

1. Agnello D., Herve C.A., Lavaux A., Darniot M., Guillon P., Charpilienne A., Pothier P. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice. J. Virol. 2006, 80:3823-3832.
2. Antohe F., Radulescu L., Gafencu A., Ghetie V., Simionescu M. Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Hum. Immunol. 2001, 62:93-105.
3. Besser T.E., Gay C.C., McGuire T.C., Evermann J.F. Passive immunity to bovine rotavirus infection associated with transfer of serum antibody into the intestinal lumen. J. Virol. 1988, 62:2238-2242.
4. Besser T.E., McGuire T.C., Gay C.C., Pritchett L.C. Transfer of functional immunoglobulin G (IgG) antibody into the gastrointestinal tract accounts for IgG clearance in calves. J. Virol. 1988, 62:2234-2237.
5. Burns J.W., Siadat-Pajouh M., Krishnaney A.A., Greenberg H.B. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996, 272:104-107.
6. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C., Greenberg H.B., Herrmann J.E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 1998, 72:5757-5761.
7. Choi A.H., Basu M., McNeal M.M., Clements J.D., Ward R.L. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J. Virol. 1999, 73:7574-7581.
8. Choi A.H., Basu M., McNeal M.M., Flint J., VanCott J.L., Clements J.D., Ward R.L. Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J. Virol. 2000, 74:11574-11580.
9. Choi A.H., McNeal M.M., Basu M., Flint J.A., Stone S.C., Clements J.D., Bean J.A., Poe S.A., VanCott J.L., Ward R.L. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. Vaccine 2002, 20:3310-3321.
10. Dong J.L., Liang B.G., Jin Y.S., Zhang W.J., Wang T. Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection. Virology 2005, 339:153-163.
11. Feng N., Lawton J.A., Gilbert J., Kuklin N., Vo P., Prasad B.V., Greenberg H.B. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J. Clin. Invest. 2002, 109:1203-1213.
12. Fernandez F.M., Conner M.E., Hodgins D.C., Parwani A.V., Nielsen P.R., Crawford S.E., Estes M.K., Saif L.J. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine 1998, 16:507-516.
13. McNeal M.M., Basu M., Bean J.A., Clements J.D., Lycke N.Y., Ramne A., Lowenadler B., Choi A.H., Ward R.L. Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge. Vaccine 2007, 25:6224-6231.
14. McNeal M.M., VanCott J.L., Choi A.H., Basu M., Flint J.A., Stone S.C., Clements J.D., Ward R.L. CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J. Virol. 2002, 76:560-568.
15. O'Neal C.M., Clements J.D., Estes M.K., Conner M.E. Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge. J. Virol. 1998, 72:3390-3393.
16. O'Neal C.M., Crawford S.E., Estes M.K., Conner M.E. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 1997, 71:8707-8717.
17. Parez N., Fourgeux C., Mohamed A., Dubuquoy C., Pillot M., Dehee A., Charpilienne A., Poncet D., Schwartz-Cornil I., Garbarg-Chenon A. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J. Virol. 2006, 80:1752-1761.
18. Parreno V., Bejar C., Vagnozzi A., Barrandeguy M., Costantini V., Craig M.I., Yuan L., Hodgins D., Saif L., Fernandez F. Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus. Vet. Immunol. Immunopathol. 2004, 100:7-24.
19. Saif L.J., Redman D.R., Smith K.L., Theil K.W. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows. Infect. Immun. 1983, 41:1118-1131.
20. Saif L.J., Weilnau P., Miller K., Stitzlein L. Isotypes of intestinal and systemic antibodies in colostrum-fed and colostrum-deprived calves challenged with rotavirus. Adv. Exp. Med. Biol. 1987, 216B:1815-1823.
21. Schwartz-Cornil I., Benureau Y., Greenberg H., Hendrickson B.A., Cohen J. Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J. Virol. 2002, 76:8110-8117.
22. Tang B., Gilbert J.M., Matsui S.M., Greenberg H.B. Comparison of the rotavirus gene 6 from different species by sequence analysis and localization of subgroup-specific epitopes using site-directed mutagenesis. Virology 1997, 237:89-96.
23. To T.L., Ward L.A., Yuan L., Saif L.J. Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J. Gen. Virol. 1998, 79(Pt 11):2661-2672.
24. VanCott J.L., Prada A.E., McNeal M.M., Stone S.C., Basu M., Huffer B., Smiley K.L., Shao M., Bean J.A., Clements J.D., Choi A.H., Ward R.L. Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates. J. Virol. 2006, 80:4949-4961.
25. Yu J., Langridge W. Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice. Transgenic Res. 2003, 12:163-169.